| 1 |
Huang J, Song Z, Wei B, Li Q, Lin P, Li H, Dong K. Immunological evaluation of patients with Alzheimer's disease based on mitogen-stimulated cytokine productions and mitochondrial DNA indicators. BMC Psychiatry 2023;23:145. [PMID: 36890488 DOI: 10.1186/s12888-023-04634-x] [Reference Citation Analysis]
|
| 2 |
Shirin Sharifi, Saeid Bashirian, Alireza Soltanian, Salman Khazaei. Predictors of COVID-19 related death in elderly patients hospitalized due to COVID-19 infection: a cross-sectional study in the west of Iran. Z Gesundh Wiss 2023. [ DOI: 10.1007/s10389-023-01868-7] [Reference Citation Analysis]
|
| 3 |
Wang Y, Zhi H, Zhang X. Effect of Huangdisan grain on improving cognitive impairment in VD rats and its mechanism in immune inflammatory response. J Neuroimmunol 2023;377:578058. [PMID: 36871311 DOI: 10.1016/j.jneuroim.2023.578058] [Reference Citation Analysis]
|
| 4 |
Vázquez-Mojena Y, Rodríguez-Córdova Y, Dominguez-Barrios Y, León-Arcia K, Miranda-Becerra D, Gonzalez-Zaldivar Y, Guerra-Bustillos G, Ziemann U, Auburger G, Rodríguez-Labrada R, Robinson-Agramonte MLÁ, Velázquez-Pérez L. Peripheral Inflammation Links with the Severity of Clinical Phenotype in Spinocerebellar Ataxia 2. Mov Disord 2023. [PMID: 36811296 DOI: 10.1002/mds.29359] [Reference Citation Analysis]
|
| 5 |
Lee TL, Ding Z, Chan AS. Can transcranial photobiomodulation improve cognitive function? A systematic review of human studies. Ageing Res Rev 2023;83:101786. [PMID: 36371017 DOI: 10.1016/j.arr.2022.101786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Rubio T, Viana R, Moreno-Estellés M, Campos-Rodríguez Á, Sanz P. TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy. Neurobiol Dis 2023;176:105964. [PMID: 36526090 DOI: 10.1016/j.nbd.2022.105964] [Reference Citation Analysis]
|
| 7 |
Elbandy M. Anti-Inflammatory Effects of Marine Bioactive Compounds and Their Potential as Functional Food Ingredients in the Prevention and Treatment of Neuroinflammatory Disorders. Molecules 2022;28. [PMID: 36615197 DOI: 10.3390/molecules28010002] [Reference Citation Analysis]
|
| 8 |
Özdek E, Han S. BEYİN YAŞLANMASINDA MOLEKÜLER MEKANİZMALAR. Ankara Ecz Fak Derg 2022;47:1-1. [DOI: 10.33483/jfpau.1099963] [Reference Citation Analysis]
|
| 9 |
Bowirrat A. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis. J Pers Med 2022;12. [PMID: 36579548 DOI: 10.3390/jpm12111817] [Reference Citation Analysis]
|
| 10 |
Guo Y, Luo N, Kang X. Potential mechanism of the Shunaoxin pill for preventing cognitive impairment in type 2 diabetes mellitus. Front Neurol 2022;13:977953. [DOI: 10.3389/fneur.2022.977953] [Reference Citation Analysis]
|
| 11 |
Jing H, Yan N, Fan R, Li Z, Wang Q, Xu K, Hu X, Zhang L, Duan X. Arsenic Activates the NLRP3 Inflammasome and Disturbs the Th1/Th2/Th17/Treg Balance in the Hippocampus in Mice. Biol Trace Elem Res 2022. [PMID: 36100822 DOI: 10.1007/s12011-022-03421-1] [Reference Citation Analysis]
|
| 12 |
Chen W, Wang J, Yang H, Sun Y, Chen B, Liu Y, Han Y, Shan M, Zhan J. Interleukin 22 and its association with neurodegenerative disease activity. Front Pharmacol 2022;13:958022. [DOI: 10.3389/fphar.2022.958022] [Reference Citation Analysis]
|
| 13 |
Yousaf M, Chang D, Liu Y, Liu T, Zhou X. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders. Molecules 2022;27:4961. [DOI: 10.3390/molecules27154961] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 14 |
Shi Y, Wei B, Li L, Wang B, Sun M. Th17 cells and inflammation in neurological disorders: Possible mechanisms of action. Front Immunol 2022;13:932152. [DOI: 10.3389/fimmu.2022.932152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Kim R, Kim HJ, Shin JH, Lee CY, Jeon SH, Jeon B. Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's Disease. Mov Disord 2022. [PMID: 35596676 DOI: 10.1002/mds.29056] [Reference Citation Analysis]
|
| 16 |
Zuliani G, Gallerani M, Maietti E, Reverberi R, Romagnoli T, Cervellati C, Brombo G. Dementia and Related Comorbidity: Analysis of 2 Years of Admissions to Italian Hospitals. Alzheimer Dis Assoc Disord 2022. [PMID: 35383579 DOI: 10.1097/WAD.0000000000000500] [Reference Citation Analysis]
|
| 17 |
Michelena G, Casas M, Eizaguirre MB, Pita MC, Cohen L, Alonso R, Garcea O, Silva BA. ¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis. Mult Scler Relat Disord 2022;57:103368. [PMID: 35158474 DOI: 10.1016/j.msard.2021.103368] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 18 |
Rönnbäck L, Johansson B. Long-Lasting Pathological Mental Fatigue After Brain Injury–A Dysfunction in Glutamate Neurotransmission? Front Behav Neurosci 2022;15:791984. [DOI: 10.3389/fnbeh.2021.791984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Lee D, Jo H, Go C, Jang Y, Chu N, Bae S, Kang D, Kim Y, Kang JS. The Roles of IL-22 and Its Receptor in the Regulation of Inflammatory Responses in the Brain. Int J Mol Sci 2022;23:757. [PMID: 35054942 DOI: 10.3390/ijms23020757] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 20 |
Gao LN, Yan M, Zhou L, Wang J, Sai C, Fu Y, Liu Y, Ding L. Puerarin Alleviates Depression-Like Behavior Induced by High-Fat Diet Combined With Chronic Unpredictable Mild Stress via Repairing TLR4-Induced Inflammatory Damages and Phospholipid Metabolism Disorders. Front Pharmacol 2021;12:767333. [PMID: 34975477 DOI: 10.3389/fphar.2021.767333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Jafari Z, Bigham A, Sadeghi S, Dehdashti SM, Rabiee N, Abedivash A, Bagherzadeh M, Nasseri B, Karimi-Maleh H, Sharifi E, Varma RS, Makvandi P. Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications. J Med Chem 2021. [PMID: 34919379 DOI: 10.1021/acs.jmedchem.1c01144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 22 |
Cervellati C, Valacchi G, Zuliani G. Early elevation of BACE1 in dementia. Aging 2021;13:24480-24481. [DOI: 10.18632/aging.203727] [Reference Citation Analysis]
|
| 23 |
Li Y, Cai M, Feng Y, Yung B, Wang Y, Gao N, Xu X, Zhang H, Huang H, Yao D. Effect of lncRNA H19 on nerve degeneration and regeneration after sciatic nerve injury in rats. Dev Neurobiol 2021. [PMID: 34818452 DOI: 10.1002/dneu.22861] [Reference Citation Analysis]
|
| 24 |
Jeleń A, Żebrowska-Nawrocka M, Szmajda-Krygier D, Mazur K, Gałecki P, Balcerczak E. Preliminary investigation of two promoter region polymorphisms of the TNFA gene in patients with recurrent depressive disorder. Biomed Rep 2021;15:105. [PMID: 34760278 DOI: 10.3892/br.2021.1481] [Reference Citation Analysis]
|
| 25 |
Silva BA, Farías MI, Miglietta EA, Leal MC, Ávalos JC, Pitossi FJ, Ferrari CC. Understanding the role of the blood brain barrier and peripheral inflammation on behavior and pathology on ongoing confined cortical lesions. Multiple Sclerosis and Related Disorders 2021. [DOI: 10.1016/j.msard.2021.103346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 26 |
Zhu M, Liu Z, Guo Y, Sultana MS, Wu K, Lang X, Lv Q, Huang X, Yi Z, Li Z. Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. J Neuroinflammation 2021;18:202. [PMID: 34526062 DOI: 10.1186/s12974-021-02261-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Gasparotto J, Senger MR, Telles de Sá Moreira E, Brum PO, Carazza Kessler FG, Peixoto DO, Panzenhagen AC, Ong LK, Campos Soares M, Reis PA, Schirato GV, Góes Valente WC, Araújo Montoya BO, Silva FP, Fonseca Moreira JC, Dal-Pizzol F, Castro-Faria-Neto HC, Gelain DP. Neurological impairment caused by Schistosoma mansoni systemic infection exhibits early features of idiopathic neurodegenerative disease. J Biol Chem 2021;297:100979. [PMID: 34303703 DOI: 10.1016/j.jbc.2021.100979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Pracucci E, Pillai V, Lamers D, Parra R, Landi S. Neuroinflammation: A Signature or a Cause of Epilepsy? Int J Mol Sci 2021;22:6981. [PMID: 34209535 DOI: 10.3390/ijms22136981] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 29 |
Romagnoli T, Ortolani B, Sanz JM, Trentini A, Seripa D, Nora ED, Capatti E, Cervellati C, Passaro A, Zuliani G, Brombo G. Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia. J Neurol Sci 2021;427:117537. [PMID: 34147956 DOI: 10.1016/j.jns.2021.117537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 30 |
Zuin M, Cervellati C, Trentini A, Passaro A, Rosta V, Zimetti F, Zuliani G. Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer's Disease: Systematic Review and Meta-Analysis. Diagnostics (Basel) 2021;11:984. [PMID: 34071695 DOI: 10.3390/diagnostics11060984] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 31 |
Zuin M, Roncon L, Passaro A, Cervellati C, Zuliani G. Metabolic syndrome and the risk of late onset Alzheimer's disease: An updated review and meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:2244-52. [PMID: 34039508 DOI: 10.1016/j.numecd.2021.03.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Wang YY, Huang ZT, Yuan MH, Jing F, Cai RL, Zou Q, Pu YS, Wang SY, Chen F, Yi WM, Zhang HJ, Cai ZY. Role of Hypoxia Inducible Factor-1α in Alzheimer's Disease. J Alzheimers Dis 2021;80:949-61. [PMID: 33612545 DOI: 10.3233/JAD-201448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 33 |
Zheng Y, Zhang J, Zhao Y, Zhang Y, Zhang X, Guan J, Liu Y, Fu J. Curcumin protects against cognitive impairments in a rat model of chronic cerebral hypoperfusion combined with diabetes mellitus by suppressing neuroinflammation, apoptosis, and pyroptosis. Int Immunopharmacol 2021;93:107422. [PMID: 33548579 DOI: 10.1016/j.intimp.2021.107422] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 34 |
Zimetti F, Adorni MP, Marsillach J, Marchi C, Trentini A, Valacchi G, Cervellati C. Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review. Oxid Med Cell Longev 2021;2021:6695796. [PMID: 33505588 DOI: 10.1155/2021/6695796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 35 |
Li T, Zhu YZ. Stress and Inflammation. Oxidative Stress 2021. [DOI: 10.1007/978-981-16-0522-2_12] [Reference Citation Analysis]
|
| 36 |
Tan BL, Norhaizan ME. Introduction and Background. The Role of Antioxidants in Longevity and Age-Related Diseases 2021. [DOI: 10.1007/978-3-030-82859-2_1] [Reference Citation Analysis]
|
| 37 |
Miceli V, Russelli G, Iannolo G, Gallo A, Lo Re V, Agnese V, Sparacia G, Conaldi PG, Bulati M. Role of non-coding RNAs in age-related vascular cognitive impairment: An overview on diagnostic/prognostic value in Vascular Dementia and Vascular Parkinsonism. Mech Ageing Dev 2020;191:111332. [PMID: 32805261 DOI: 10.1016/j.mad.2020.111332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 38 |
Schirinzi T, Landi D, Liguori C. COVID-19: dealing with a potential risk factor for chronic neurological disorders. J Neurol 2021;268:1171-8. [PMID: 32852580 DOI: 10.1007/s00415-020-10131-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 39 |
Zuin M, Cervellati C, Trentini A, Roncon L, Guasti P, Zuliani G. Methylenetetrahydrofolate reductase C667T polymorphism and susceptibility to late-onset Alzheimer's disease in the Italian population. Minerva Med 2021;112:365-71. [PMID: 32700867 DOI: 10.23736/S0026-4806.20.06801-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 40 |
Nuzzo D, Picone P. Potential neurological effects of severe COVID-19 infection. Neurosci Res 2020;158:1-5. [PMID: 32628969 DOI: 10.1016/j.neures.2020.06.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 41 |
Wang Q, Yang W, Zhang J, Zhao Y, Xu Y. TREM2 Overexpression Attenuates Cognitive Deficits in Experimental Models of Vascular Dementia. Neural Plast 2020;2020:8834275. [PMID: 32617097 DOI: 10.1155/2020/8834275] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 42 |
Romani A, Trentini A, Flier WMV, Bellini T, Zuliani G, Cervellati C, Teunissen CE. Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia. Antioxidants (Basel) 2020;9:E456. [PMID: 32466344 DOI: 10.3390/antiox9050456] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
